Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 293

    New GSK shingles vaccine off to strong start in key US market

    New GSK shingles vaccine off to strong start in key US market

    Ruby Khatun Khatun12 April 2018 9:45 AM IST
    LONDON: GlaxoSmithKline's (GSK) new shingles vaccine - a priority product as the company strives to improve its drugs line-up - has won more than 90...
    FDA needs more time to review AbbVie, Neurocrines uterine pain drug

    FDA needs more time to review AbbVie, Neurocrine's uterine pain drug

    Ruby Khatun Khatun12 April 2018 9:30 AM IST
    AbbVie Inc and Neurocrine Biosciences Inc said the U.S. Food and Drug Administration (FDA) notified the companies that it requires more time to review...
    Dr Reddys gets EIR from USFDA for Cuernavaca plant in Mexico

    Dr Reddy's gets EIR from USFDA for Cuernavaca plant in Mexico

    Ruby Khatun Khatun11 April 2018 10:15 AM IST
    New Delhi: Drug firm Dr Reddy's Laboratories said it has received establishment inspection report from the US health regulator for its Cuernavaca...
    Mylan to buy MS drug marketing rights from Mapi Pharma

    Mylan to buy MS drug marketing rights from Mapi Pharma

    Ruby Khatun Khatun11 April 2018 9:45 AM IST
    Mylan NV will buy global marketing rights to an experimental multiple sclerosis treatment from Israel’s Mapi Pharma, aiming to strengthen its position...
    Ionis may get up to 300 million dollar in licensing deal with AstraZeneca

    Ionis may get up to 300 million dollar in licensing deal with AstraZeneca

    Ruby Khatun Khatun11 April 2018 9:30 AM IST
    Ionis Pharmaceuticals Inc said a licensing deal for its fatty liver disease treatment with AstraZeneca Plc could fetch up to $300 million in milestone...
    Alembic Pharma gets USFDA approval for Acyclovir ointment

    Alembic Pharma gets USFDA approval for Acyclovir ointment

    Ruby Khatun Khatun10 April 2018 10:30 AM IST
    New Delhi: Alembic Pharma said it has received approval from the US health regulator its Acyclovir ointment USP, used for the treatment of genital...
    SMT wins tenders at five Brazilian Hospitals

    SMT wins tenders at five Brazilian Hospitals

    Ruby Khatun Khatun10 April 2018 10:00 AM IST
    Mumbai: SMT (Sahajanand Medical Technologies Pvt. Ltd.) has succeeded in bagging prestigious tenders amongst Brazilian hospitals for the distribution...
    USFDA restricts sale of Bayers Essure birth control device

    USFDA restricts sale of Bayer's Essure birth control device

    Ruby Khatun Khatun10 April 2018 9:45 AM IST
    The U.S. Food and Drug Administration (FDA) on Monday slapped restrictions on the sale of Bayer AG’s implanted birth control device Essure, two years...
    Merck

    Merck's Keytruda helps lung cancer patients live longer in trial

    Ruby Khatun Khatun10 April 2018 9:30 AM IST
    Merck & Co’s blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing...
    Sebi exempts trust linked to Alembic, Alembic Pharma from open offer requirement

    Sebi exempts trust linked to Alembic, Alembic Pharma from open offer requirement

    Ruby Khatun Khatun9 April 2018 11:00 AM IST
    New Delhi: Markets regulator Sebi has exempted a private family trust related to the promoter group of Alembic Pharmaceuticals and Alembic from making...
    Glenmark recalls 100,000 bottles of anti-inflammatory drug over incorrect instrictions

    Glenmark recalls 100,000 bottles of anti-inflammatory drug over incorrect instrictions

    Ruby Khatun Khatun9 April 2018 10:00 AM IST
    New Delhi: Glenmark Pharmaceuticals is recalling over 100,000 bottles of anti-inflammatory Indomethacin capsules from the US market due to incorrect...
    VLCC to open 50 institutes in India; plans to go international

    VLCC to open 50 institutes in India; plans to go international

    Ruby Khatun Khatun9 April 2018 9:45 AM IST
    New Delhi: Beauty and wellness firm VLCC is on the expansion spree with a target to add 50 new training institutes in India over the next five...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok